Project Grant R01HL172848
Award Date
6/15/24
Completion Date
3/31/28
Dollars Obligated
$2M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19140, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $616,000.00 to Northwestern University over a 5-year period beginning September 1, 2024. The grant supports research to investigate the role of mitochondrial metabolism and the integrated stress response in alveolar epithelial cell differentiation, with the goal of understanding the mechanisms driving heterogeneous outcomes in...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $156,665 to The Trustees of the University of Pennsylvania to conduct research on mesenchymal cell plasticity and signaling in lung regeneration. The research aims to examine how specific mesenchymal cell lineages contribute to adaptive versus maladaptive epithelial regeneration after viral lung injury, with a focus on the role of...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,540 to The Trustees of the University of Pennsylvania for a 2-year research project starting on September 1, 2024. The project aims to investigate the impact of aging on mitochondrial quality control, metabolic disruption, and alveolar epithelial type 2 (AT2) progenitor cell function in pulmonary fibrosis. The research...
The $693,306 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to examine the role of fatty acid oxidation and the mitochondrial enzyme carnitine palmitoyltransferase 1A (CPT1A) in regulating alveolar epithelial type II (AT2) cell differentiation and resilience against lung fibrosis. The research, conducted by The Ohio State University, aims to determine if fatty acid oxidation...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,061,189.00 to the Regents of the University of Michigan to conduct research on immune crosstalk in lung injury and fibrosis. The primary objectives are to study epithelial regulation of fibrosis and innate immunity against bacterial infections in the lungs, as well as test delivery of targeted therapies using nanoparticles. The...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA Program 93.837 - Cardiovascular Diseases Research provides $777,048 to support research at The Trustees of Columbia University in the City of New York, Health Sciences Division. The research aims to better understand how enhancing gap junctional channels between alveolar myeloid cells and the alveolar epithelium can improve host resilience against acute lung injury (ALI) and acute respiratory...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $148,568 Project Grant to the Mayo Clinic under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The grant will fund research investigating the role of pleural mesothelial cells in lung injury, repair, and regeneration. The study aims to provide a better understanding of the signaling and functional roles of these cells in the context of lung injury, fibrosis, and repair, with a focus on examining their...
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the role of the tau protein in regulating microtubule dynamics and mitochondrial function to control the organization and regeneration of alveolar epithelial cells in the lungs. The $563,746 grant, awarded to Duke University with a period of performance from August 10, 2024, to May 31, 2029, will utilize genetic...
This federal Project Grant award, with ID R01HL177013, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The $684,814 award supports research to investigate how lung tissue factors can alter the inflammatory response to viral infections and suppress alveolar stem cells in emphysema, a subtype of chronic obstructive pulmonary disease (COPD). Key objectives include determining the mechanisms by which stromal...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $602,955 to National Jewish Health to study the reparative functions of distinct airspace macrophage subsets in the lung following inflammation. The primary objectives are to: 1) Identify specialized functions and molecular drivers of airspace macrophage subsets during resolution of inflammation and lung repair, 2) Determine the...